Androgen receptor (AR) agonists inhibit AR- and estrogen-receptor-positive breast cancer

被引：0
|
作者：
Asemota, Sarah [1 ]
Ponnusamy, Suriyan [1 ]
Thiyagarajan, Thirumagal [1 ]
Narayanan, Ramesh [1 ]
机构：
[1] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1777
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Computational modeling of androgen receptor (AR) and estrogen receptor as predictive biomarkers of response to AR agonists and antagonists
    Wei, Lixuan
    Gao, Huanyao
    Yu, Jia
    Liu, Duan
    Zhang, Huan
    Thanh Nguyen
    Passow, Marie R.
    Carter, Jodi M.
    Weinshilboum, Richard M.
    Ingle, James N.
    Wang, Liewei
    [J]. CANCER RESEARCH, 2021, 81 (04)
  • [2] Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer?
    Bronte, Giuseppe
    Rocca, Andrea
    Ravaioli, Sara
    Scarpi, Emanuela
    Bonafe, Massimiliano
    Puccetti, Maurizio
    Maltoni, Roberta
    Andreis, Daniele
    Martinelli, Giovanni
    Bravaccini, Sara
    [J]. JOURNAL OF ONCOLOGY, 2019, 2019
  • [3] The potential clinical benefit of targeting androgen receptor (AR) in estrogen-receptor positive breast cancer cells treated with Exemestane
    Amaral, Cristina
    Augusto, Tiago, V
    Almada, Marta
    Cunha, Sara C.
    Correia-da-Silva, Georgina
    Teixeira, Natercia
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2020, 1866 (05):
  • [4] A new class of agents for estrogen-receptor-positive breast cancer
    Ekoue, Dede N.
    Unni, Nisha
    Raj, Ganesh V.
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (04) : 325 - 328
  • [5] Estrogen Receptor (ER) and Androgen Receptor (AR) in Normal Human Breast Tissue and Breast Carcinoma
    Weinsensel, J.
    Tang, P.
    Hicks, D.
    Berenson, M.
    diSant'Agnese, A.
    Wang, X.
    [J]. LABORATORY INVESTIGATION, 2009, 89 : 74A - 74A
  • [6] Estrogen Receptor (ER) and Androgen Receptor (AR) in Normal Human Breast Tissue and Breast Carcinoma
    Weinsensel, J.
    Tang, P.
    Hicks, D.
    Berenson, M.
    diSant'Agnese, A.
    Wang, X.
    [J]. MODERN PATHOLOGY, 2009, 22 : 74A - 74A
  • [7] The predictive role of estrogen receptor beta (ER-β) in androgen receptor (AR)-positive triple-negative breast cancer (TNBC)
    Anestis, A.
    Mihailidou, C.
    Theocharis, S.
    Tryfonopoulos, D.
    Korogiannos, A.
    Koumarianou, A.
    Xingi, E.
    Kontos, M.
    Papavassiliou, A. G.
    Karamouzis, M. V.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [8] Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells
    Chang, Sharon B.
    Miron, Penelope
    Miron, Alexander
    Iglehart, J. Dirk
    [J]. JOURNAL OF SURGICAL RESEARCH, 2007, 138 (01) : 37 - 44
  • [9] Impact of Progesterone Receptor (PR) and Androgen Receptor (AR) on Aromatase Inhibitor Treated Estrogen Receptor (ER) Positive Metastatic Breast Carcinomas
    Wang, Xi
    Kadambi, Sindhuja
    Eckert-Davis, Laura
    Strawderman, Myla
    Meacham, Philip
    Khatib, Hasan
    Yang, Qi
    Dhakal, Ajay
    [J]. LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 281 - 281
  • [10] Impact of Progesterone Receptor (PR) and Androgen Receptor (AR) on Aromatase Inhibitor Treated Estrogen Receptor (ER) Positive Metastatic Breast Carcinomas
    Wang, Xi
    Kadambi, Sindhuja
    Eckert-Davis, Laura
    Strawderman, Myla
    Meacham, Philip
    Khatib, Hasan
    Yang, Qi
    Dhakal, Ajay
    [J]. MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 281 - 281
12345